Accueil > Actualité
Actualite financiere : Actualite bourse

Novo Nordisk: ups sales view after nine-month update

( - Danish drugmaker Novo Nordisk said on Friday that it was "very satisfied" with its sales growth during the first nine months of 2019, prompting a slight rise in the group's shares.

The company has raised its 2019 sales growth outlook to 5%-6% at constant exchange rates (CER), compared to 4-6% previously, while operating profit growth is still expected to be 4-6% at CER.

The world's biggest insulin producer said on Friday that sales increased by 5% at constant exchange rates to 89.6 billion Danish kronor (about 12 billion euros) in the first nine months of 2019.

Sales of obesity drugs jumped by 50% in particular, the group said.

Novo Nordisk's operating profit rose by 5% at constant exchange rates over the period, the group added.

The shares are currently up 1.8% at 372.7 Danish kronor on the Nasdaq Nordic market.

Copyright (c) 2019 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.